Total Time: 32:11 | File Size: 14.7 MB
Topics covered in this edition:
Canagliflozin Provides Durable Glycemic Improvements and Body Weight Reduction Over 104 Weeks Versus Glimepiride in Patients With Type 2 Diabetes on Metformin: A Randomized, Double-Blind, Phase 3 Study
Dapagliflozin Improves Glycemic Control and Reduces Body Weight as Add-on Therapy to Metformin Plus Sulfonylurea: A 24-Week Randomized, Double-Blind Clinical Trial Â
Combination of Empagliflozin and Linagliptin as Second-Line Therapy in...
View our Privacy Policy & Terms of Use
This free content is available to registered users.
Becoming a Registered User only requires your name and email address.
Podcast Type:
Diabetes Core
Publication Date:
Tuesday, February 24, 2015 - 00:00